Agios Pharmaceuticals, Inc. (AGIO) stock forecast — our track record
1 completed AGIO stock prediction — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our AGIO forecasts have done
Lyra published 1 AGIO stock forecast for Agios Pharmaceuticals, Inc., starting on July 2, 2025. The prediction used a short term (0 to 3 months) horizon, and its window closed on September 30, 2025. It was published before the outcome was known, then closed and scored after the window ended. This track record covers only that closed call.
Overall, the call did not reach its target. There were no misses, because the result was partial rather than a full miss. The average success score was 50%. The short term average score was also 50%, matching the only horizon used. The stock rose as much as 17.3% during the window, while the forecast had called for 45% growth.
The best call was the July 2, 2025 short term forecast. It predicted 45% growth, and the stock actually rose as much as 17.3%. It did not reach the target. The worst call was the same July 2, 2025 forecast, with the same 45% predicted growth, 17.3% peak gain, and 50% score. With 1 closed prediction, the record was partial: it captured a positive move, but it did not reach the forecast target.
Written from the closed signals below; refreshed when new signals close.
Closed AGIO signals
| Closed | Timeframe | Predicted | Peak result | Outcome | Days to target | |
|---|---|---|---|---|---|---|
| September 30, 2025 |
Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.
Share this receipt
The full public record for this symbol — wins and misses. Paste the link anywhere — it unfurls as the card above.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way AGIO was. No deleted misses, no cherry-picking.